Keywords: NIH; NIGMS; NCATS; NIMH; NINDS; Venture capital; Advocacy; Philanthropy; Alzheimer's disease; Clinical trials; Pharmaceutical industry; Biotechnology companies; SBIR; STTR;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: 11BHSD; 11β-hydroxysteroid dehydrogenase; ACTH; adrenocorticotropic hormone; AE; adverse event; ALT; alanine aminotransferase; AUC; area under the curve; BMI; body mass index; CBG; cortisol binding globulin; CL/F; apparent total clearance of the drug fro
Keywords: PSI-SF; Parenting Stress Index short form; VP; very preterm; NCATS; Nursing Child Assessment Teaching Scale; HOME; Home Observation for Measurement of the Environment; Very preterm; Mother-infant interaction; Twins; Parenting stress;
Keywords: IEM; inborn errors of metabolism; NIH; National Institutes of Health; ODS; Office of Dietary Supplements; ORDR; Office of Rare Diseases Research; HRSA; Health Resources and Services Administration; PKU; phenylketonuria; PAH; phenylalanine hydroxylase; PHE
Molecular characterization of physis tissue by RNA sequencing
Keywords: NCATS; National Center for Advancing Translational Sciences; NIH; National Institutes of Health; COL2A1; collagen Type II alpha 1 chain; COL6A1; collagen type VI alpha 1 chain; COL9A1; collagen type IX alpha 1 chain; COL9A2; collagen type IX alpha 2 chain
Regulatory-accepted drug development tools are needed to accelerate innovative CNS disease treatments
Keywords: ACR; American College of Radiology; AD; Alzheimer disease; ADNI; Alzheimer's Disease Neuroimaging Initiative; ALS; Amyotrophic Lateral Sclerosis; ASD; Autism Spectrum Disorder; BBB; Blood-Brain-Barrier; BEST; Biomarkers, Endpoints and other Tools; BLA; Bi
Insight into the phenotype of infants with Pompe disease identified by newborn screening with the common c.-32-13TÂ >Â G “late-onset” GAA variant
Keywords: NBS; Newborn screening; IOPD; Infantile onset Pompe disease; LOPD; Late onset Pompe disease; GAA; Acid α-glucosidase; ERT; Enzyme replacement therapy; RUSP; Recommended uniform screening panel; CK; Creatine kinase; Glc4; Urinary glucose tetrasaccharide;